Pharmaceutical products

Description

Procurement exercise for a contract for the supply of stockpiled medicines to include: lopinavir/ritonavir — tablets or oral solution; hydroxychloroquine — tablets; dexamethasone — oral solution or tablets and azithromycin — capsules, tablets or oral solution. Deliveries will be required over an initial period between 15th June and 30 September 2020 with an option to extend for up to an additional 4 months. The Authority’s preferred presentations and strengths of the medicines and alternative presentations and strengths and presentations which may be acceptable, are specified in the procurement documents. This procurement exercise may result in one or more contracts for the provision of lopinavir/ritonavir tablets or oral solution. The volumes required by the Authority are up to 1.4 million tablets in packs of up to 120 tablets This procurement exercise may result in one or more contracts for the provision of hydroxychloroquine tablets. The volumes required by the authority are up to 16 million tablets in packs of up to 100 tablets. This procurement exercise may result in one or more contracts for the provision of dexamethasone 2 mg/5 ml oral solution. The volumes required by the authority are up to 7 000 litres in either 75 ml or 150 ml bottles. This procurement exercise may result in one or more contracts for the provision of Azithromycin 250 mg capsules. The approximate volumes required by the authority are up to 20 million capsules in packs of up to 6 capsules.